The probability of residual tumor detection in the second transurethral resection of PT1 urothelial bladder cancer according to the risk factors

dc.authorid0000-0001-9244-3818
dc.contributor.authorCulpan, M.
dc.contributor.authorKazan, O.
dc.contributor.authorAcar, H. Cansu
dc.contributor.authorIplikci, A.
dc.contributor.authorAtis, G.
dc.contributor.authorYildirim, A.
dc.date.accessioned2025-05-10T19:48:19Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective: To analyze the predictive factors for residual tumors in the second resection after the initial transurethral resection of bladder tumor (TUR-BT) in patients with pT1 tumors and to develop a simple method to predict the probability of residual tumor detection.Material and methods: Patients with pT1 bladder cancer who underwent a second resection within 2 to 6 weeks after the initial transurethral resection of bladder tumor were included in our retrospective study. The patients' demographics and the tumor characteristics of the initial and second resections were recorded.Results: A total of 144 patients were included in our analysis with a 53-month follow-up. In the univariate logistic regression analysis, tumor grade, concomitant carcinoma in situ, macros-copic appearance of the tumor (solid vs papillary), and presence of a variant histology, were significant risk factors for residual tumor. In the multivariate analysis, tumor grade was the only independent predictor of residual tumor at second transurethral resection (OR: 5.62, 95% CI: 1.228-25.708, p = 0.026). According to our findings, the patients with the highest risk have a 90.9% residual tumor detection probability at the second resection, and the patients with the lowest risk have 25.4%Conclusions: Tumor grade, macroscopic appearance of the tumor (solid vs papillary), and conco-mitant carcinoma in situ, were important predictors of residual tumors at second resection of primary pT1 non-muscle invasive bladder cancer patients. We were able to calculate the pro-bability of residual tumor which helped us determine risk adapted strategies according to these probabilities.(c) 2022 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.
dc.identifier.doi10.1016/j.acuro.2021.07.002
dc.identifier.endpage430
dc.identifier.issn0210-4806
dc.identifier.issn1699-7980
dc.identifier.issue7
dc.identifier.pmid35725972
dc.identifier.scopus2-s2.0-85125484324
dc.identifier.scopusqualityQ3
dc.identifier.startpage423
dc.identifier.urihttps://doi.org/10.1016/j.acuro.2021.07.002
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11673
dc.identifier.volume46
dc.identifier.wosWOS:000861282900006
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Espana
dc.relation.ispartofActas Urologicas Espanolas
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectBladder cancer
dc.subjectPredictive factors
dc.subjectRe-TUR
dc.subjectResidual tumor
dc.subjectSecond resection
dc.titleThe probability of residual tumor detection in the second transurethral resection of PT1 urothelial bladder cancer according to the risk factors
dc.typeArticle

Dosyalar